Artículos de revistas sobre el tema "FOOD AND DRUGS ADMINISTRATION"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "FOOD AND DRUGS ADMINISTRATION".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Hutcheon, Duncan E. "Drugs Approved by Food & Drug Administration". Journal of Clinical Pharmacology 29, n.º 5 (mayo de 1989): 478–79. http://dx.doi.org/10.1002/j.1552-4604.1989.tb03366.x.
Texto completoFurlan, Anthony J. y Marc Fisher. "Devices, Drugs, and the Food and Drug Administration". Stroke 36, n.º 2 (febrero de 2005): 398–99. http://dx.doi.org/10.1161/01.str.0000153057.07181.94.
Texto completoTsimberidou, Apostolia-Maria, Fadi Braiteh, David J. Stewart y Razelle Kurzrock. "Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial". Journal of Clinical Oncology 27, n.º 36 (20 de diciembre de 2009): 6243–50. http://dx.doi.org/10.1200/jco.2009.23.6018.
Texto completoHaffner, Marlene E. y John V. Kelsey. "Evaluation of Orphan Products by the U.S. Food and Drug Administration". International Journal of Technology Assessment in Health Care 8, n.º 4 (1992): 647–57. http://dx.doi.org/10.1017/s0266462300002348.
Texto completoRangaraj, Nagarjun, Sunitha Sampathi, Vijayabhaskarreddy Junnuthula, Praveen Kolimi, Preethi Mandati, Sagar Narala, Dinesh Nyavanandi y Sathish Dyawanapelly. "Fast-Fed Variability: Insights into Drug Delivery, Molecular Manifestations, and Regulatory Aspects". Pharmaceutics 14, n.º 9 (27 de agosto de 2022): 1807. http://dx.doi.org/10.3390/pharmaceutics14091807.
Texto completoKharitonovа, L. A., A. M. Zaprudnov y K. I. Grigoriev. "Mandatory assessment of trophological status and nutrition in children in drugs prescribing". Experimental and Clinical Gastroenterology, n.º 1 (2 de mayo de 2020): 4–14. http://dx.doi.org/10.31146/1682-8658-ecg-173-1-4-14.
Texto completoSharma, Ajitha y Rathnakar Up. "REVISED FOOD AND DRUG ADMINISTRATION RISK CATEGORIES OF DRUGS DURING PREGNANCY". Asian Journal of Pharmaceutical and Clinical Research 10, n.º 7 (1 de julio de 2017): 77. http://dx.doi.org/10.22159/ajpcr.2017.v10i7.16539.
Texto completoButler, O. D., Woodrow M. Knight y Jack C. Taylor. "The Regulation of Production Drugs by the Food and Drug Administration". Professional Animal Scientist 2, n.º 1 (junio de 1986): 14–17. http://dx.doi.org/10.15232/s1080-7446(15)32415-3.
Texto completoBlankfield, Robert P. y Imran H. Iftikhar. "Food and Drug Administration Regulation of Drugs That Raise Blood Pressure". Journal of Cardiovascular Pharmacology and Therapeutics 20, n.º 1 (6 de mayo de 2014): 5–8. http://dx.doi.org/10.1177/1074248414531852.
Texto completoAshley, Donald D. "Clarifying Misconceptions About US Food and Drug Administration Unapproved Drugs Program". Anesthesia & Analgesia 127, n.º 6 (diciembre de 2018): 1292–94. http://dx.doi.org/10.1213/ane.0000000000003852.
Texto completoSukhatme, Vidula V., Suresh S. Ramalingam, Rafi Ahmed y Vikas P. Sukhatme. "Repurposing Food and Drug Administration–Approved Drugs to Promote Antitumor Immunity". Cancer Journal 25, n.º 2 (2019): 88–99. http://dx.doi.org/10.1097/ppo.0000000000000368.
Texto completoOfosu, Frederick A. "The United States Food and Drugs Administration Approves a Generic Enoxaparin". Clinical and Applied Thrombosis/Hemostasis 17, n.º 1 (15 de diciembre de 2010): 5–8. http://dx.doi.org/10.1177/1076029610389028.
Texto completoYao, Hsien-Tsung, Jia-Hsuan Lin, Yun-Ta Liu, Mei-Ling Li y Wenchang Chiang. "Food–Drug Interaction between the Adlay Bran Oil and Drugs in Rats". Nutrients 11, n.º 10 (15 de octubre de 2019): 2473. http://dx.doi.org/10.3390/nu11102473.
Texto completoTao, Rachel E., Stuti Prajapati, Jessica N. Pixley, Ayman Grada y Steven R. Feldman. "Oral Tetracycline-Class Drugs in Dermatology: Impact of Food Intake on Absorption and Efficacy". Antibiotics 12, n.º 7 (5 de julio de 2023): 1152. http://dx.doi.org/10.3390/antibiotics12071152.
Texto completoS, Shidhaye. "Effect of Food on Bioavailability of Drug through Gastro-Retentive Drug Delivery System". Bioequivalence & Bioavailability International Journal 5, n.º 1 (2021): 1–3. http://dx.doi.org/10.23880/beba-16000148.
Texto completoLloyd, Rhea, Jennifer Harris, Sonal Wadhwa y Wiley Chambers. "Food and Drug Administration approval process for ophthalmic drugs in the US". Current Opinion in Ophthalmology 19, n.º 3 (mayo de 2008): 190–94. http://dx.doi.org/10.1097/icu.0b013e3282f97fa1.
Texto completode La Garza, René y Chris E. Johanson. "The effects of food deprivation on the self-administration of psychoactive drugs". Drug and Alcohol Dependence 19, n.º 1 (enero de 1987): 17–27. http://dx.doi.org/10.1016/0376-8716(87)90083-4.
Texto completoNasr, Alexander, Thomas J. Lauterio y Matthew W. Davis. "Unapproved drugs in the united states and the food and drug administration". Advances in Therapy 28, n.º 10 (1 de septiembre de 2011): 842–56. http://dx.doi.org/10.1007/s12325-011-0059-4.
Texto completoHwang, Thomas J., Jessica M. Franklin, Christopher T. Chen, Julie C. Lauffenburger, Bishal Gyawali, Aaron S. Kesselheim y Jonathan J. Darrow. "Efficacy, Safety, and Regulatory Approval of Food and Drug Administration–Designated Breakthrough and Nonbreakthrough Cancer Medicines". Journal of Clinical Oncology 36, n.º 18 (20 de junio de 2018): 1805–12. http://dx.doi.org/10.1200/jco.2017.77.1592.
Texto completoKaplan, Robert M., Amanda J. Koong y Veronica Irvin. "Review of Evidence Supporting 2022 US Food and Drug Administration Drug Approvals". JAMA Network Open 6, n.º 8 (8 de agosto de 2023): e2327650. http://dx.doi.org/10.1001/jamanetworkopen.2023.27650.
Texto completoWard, Robert M. "Children, Drugs, and the Food and Drug Administration: Studies of Pediatric Drugs Are Beginning to Catch Up". Pediatric Annals 30, n.º 4 (1 de abril de 2001): 189–94. http://dx.doi.org/10.3928/0090-4481-20010401-06.
Texto completoTibau, Ariadna, Alberto Ocana, Geòrgia Anguera, Bostjan Seruga, Arnoud J. Templeton, Agustí Barnadas y Eitan Amir. "Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration". JAMA Oncology 2, n.º 6 (1 de junio de 2016): 744. http://dx.doi.org/10.1001/jamaoncol.2015.6479.
Texto completoMolto, Consolacion, Thomas J. Hwang, Marta Andres, Maria Borrell, Ignasi J. Gich Saladich, Agust Barnadas, Eitan Amir, Aaron S. Kesselheim y Ariadna Tibau Martorell. "Clinical benefit of breakthrough cancer drugs approved by the United States Food and Drug Administration." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 6513. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.6513.
Texto completoKayki-Mutlu, Gizem y Martin C. Michel. "A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2020". Naunyn-Schmiedeberg's Archives of Pharmacology 394, n.º 5 (16 de abril de 2021): 839–52. http://dx.doi.org/10.1007/s00210-021-02085-3.
Texto completoAebersold, Paul. "FDA Experience with Medical Countermeasures under the Animal Rule". Advances in Preventive Medicine 2012 (2012): 1–11. http://dx.doi.org/10.1155/2012/507571.
Texto completoBasin, Bhawna. "New Drugs for Breast Cancer Treatment". TEXILA INTERNATIONAL JOURNAL OF ACADEMIC RESEARCH 10, n.º 3 (28 de julio de 2023): 26–33. http://dx.doi.org/10.21522/tijar.2014.10.03.art003.
Texto completoChhim, Rebecca F., Chasity M. Shelton y Michael L. Christensen. "Recent New Drug Approvals, Part 2: Drugs Undergoing Active Clinical Studies in Children". Journal of Pediatric Pharmacology and Therapeutics 18, n.º 1 (1 de enero de 2013): 14–38. http://dx.doi.org/10.5863/1551-6776-18.1.14.
Texto completoAyele, Yohanes, Abraham Nigussie Mekuria, Assefa Tola, Kirubel Minsamo Mishore y Fisseha Bonja Geleto. "Prescription drugs use during pregnancy in Ethiopia: A systematic review and meta-analysis". SAGE Open Medicine 8 (enero de 2020): 205031212093547. http://dx.doi.org/10.1177/2050312120935471.
Texto completoBoozalis, Emily, Yevgeniy R. Semenov y Shawn G. Kwatra. "Food and drug administration approval process for dermatology drugs in the United States". Journal of Dermatological Treatment 29, n.º 6 (26 de enero de 2018): 536–38. http://dx.doi.org/10.1080/09546634.2018.1425361.
Texto completoJohnson, John R., Grant Williams y Richard Pazdur. "End Points and United States Food and Drug Administration Approval of Oncology Drugs". Journal of Clinical Oncology 21, n.º 7 (1 de abril de 2003): 1404–11. http://dx.doi.org/10.1200/jco.2003.08.072.
Texto completoSarvas, Holly, Benjamin Carlisle, Samantha Dolter, Esther Vinarov y Jonathan Kimmelman. "Impact of Precision Medicine on Efficiencies of Novel Drug Development in Cancer". JNCI: Journal of the National Cancer Institute 112, n.º 8 (13 de noviembre de 2019): 859–62. http://dx.doi.org/10.1093/jnci/djz212.
Texto completoda la Torre, Beatriz G. y Fernando Albericio. "Practical Protocols for Solid-Phase Peptide Synthesis 4.0". Methods and Protocols 5, n.º 6 (24 de octubre de 2022): 85. http://dx.doi.org/10.3390/mps5060085.
Texto completoChambers, James D., Katherine A. Clifford, Daniel E. Enright y Peter J. Neumann. "Follow-On Indications for Orphan Drugs Related to the Inflation Reduction Act". JAMA Network Open 6, n.º 8 (15 de agosto de 2023): e2329006. http://dx.doi.org/10.1001/jamanetworkopen.2023.29006.
Texto completoBateman-House, Alison, Arthur Caplan y Lisa Kearns. "Ensuring Justice in Access to Investigational Neurological Drugs". Seminars in Neurology 38, n.º 05 (octubre de 2018): 583–88. http://dx.doi.org/10.1055/s-0038-1668076.
Texto completoRomanach, John y Walter E. Block. "Medical Economics: End the FDA (Food and Drug Administration)". Winners 18, n.º 1 (31 de marzo de 2017): 43. http://dx.doi.org/10.21512/tw.v18i1.4052.
Texto completoPearson, Kay C. y Dianne L. Kennedy. "Adverse Drug Reactions and the Food and Drug Administration". Journal of Pharmacy Practice 2, n.º 4 (agosto de 1989): 209–13. http://dx.doi.org/10.1177/089719008900200403.
Texto completoTu, S. Sean, Aaron S. Kesselheim, Kathrine Wetherbee y William B. Feldman. "Changes in the Number of Continuation Patents on Drugs Approved by the FDA". JAMA 330, n.º 5 (1 de agosto de 2023): 469. http://dx.doi.org/10.1001/jama.2023.11525.
Texto completoKitchlew, Rizwana, Miqdad Haider y Saba Mir. "Awareness about appropriate practice of Sodium Polystyrene Sulfonate administration." Professional Medical Journal 27, n.º 01 (10 de enero de 2020): 52–56. http://dx.doi.org/10.29309/tpmj/2019.27.01.3184.
Texto completoGreenlees, Kevin J. "Animal Drug Human Food Safety Toxicology and Antimicrobial Resistance—The Square Peg". International Journal of Toxicology 22, n.º 2 (marzo de 2003): 131–34. http://dx.doi.org/10.1080/10915810305091.
Texto completoNaci, Huseyin, Robin Forrest, Mike Zhai, Amanda R. Stofesky y Aaron S. Kesselheim. "Characteristics of Prior Authorization Policies for New Drugs in Medicare Part D". JAMA Health Forum 4, n.º 2 (24 de febrero de 2023): e225610. http://dx.doi.org/10.1001/jamahealthforum.2022.5610.
Texto completoDhodapkar, Meera M., Joseph S. Ross y Reshma Ramachandran. "US Food and Drug Administration Review Time of Supplemental New Indication Approvals of Drugs and Biologics, 2017 to 2019". JAMA Network Open 6, n.º 6 (26 de junio de 2023): e2318889. http://dx.doi.org/10.1001/jamanetworkopen.2023.18889.
Texto completoMason, Marlys J. "Drugs or Dietary Supplements: FDA's Enforcement of DSHEA". Journal of Public Policy & Marketing 17, n.º 2 (septiembre de 1998): 296–302. http://dx.doi.org/10.1177/074391569801700212.
Texto completoSalman, Mohammad, Syed Allahsan, Manzoor Mahmood, Md Khairul Anam, Shahed Mohammad Anwar, Roksana Afrose, Md Abu Afrose, Md Ashraf Uddin Sultan y Fazlur Rahman. "New Drugs for Acute Heart Failure". University Heart Journal 7, n.º 1 (29 de marzo de 2012): 35–38. http://dx.doi.org/10.3329/uhj.v7i1.10208.
Texto completoFricker, Lloyd D. "Proteasome Inhibitor Drugs". Annual Review of Pharmacology and Toxicology 60, n.º 1 (6 de enero de 2020): 457–76. http://dx.doi.org/10.1146/annurev-pharmtox-010919-023603.
Texto completoHermida, Laura G., Manuel Sabés-Xamaní y Ramon Barnadas-Rodríguez. "Characteristics and behaviour of liposomes when incubated with natural bile salt extract: implications for their use as oral drug delivery systems". Soft Matter 10, n.º 35 (2014): 6677–85. http://dx.doi.org/10.1039/c4sm00981a.
Texto completoCupic, Vitomir, Sasa Ivanovic, Suncica Borozan, Indira Mujezinovic, Dejana Cupic-Miladinovic y Jelena Aleksic. "Antimicrobial agents in laying hens". Zbornik Matice srpske za prirodne nauke, n.º 142 (2022): 61–71. http://dx.doi.org/10.2298/zmspn2242061c.
Texto completoPivarnik, Greg. "Cells as Drugs?: Regulating the Future of Medicine". American Journal of Law & Medicine 40, n.º 2-3 (junio de 2014): 298–321. http://dx.doi.org/10.1177/009885881404000208.
Texto completoSmetana, Gerald W. "Update on Novel Drugs for Primary Care Practice: Drugs Approved by the U.S. Food and Drug Administration in 2015". Annals of Internal Medicine 164, n.º 9 (3 de mayo de 2016): W48. http://dx.doi.org/10.7326/m15-3104.
Texto completoBaldwin, Paul. "The Regulation of Dietary Supplements in the United States". Senior Care Pharmacist 37, n.º 8 (1 de agosto de 2022): 374. http://dx.doi.org/10.4140/tcp.n.2022.374.
Texto completoMilutinov, Jovana, Veljko Krstonošić, Dejan Ćirin y Nebojša Pavlović. "Emulgels: Promising Carrier Systems for Food Ingredients and Drugs". Polymers 15, n.º 10 (13 de mayo de 2023): 2302. http://dx.doi.org/10.3390/polym15102302.
Texto completo